Hudson Bay Capital Management
PAVMZ

Hudson Bay Capital Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Hudson Bay Capital Management’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-22,574
Closed -$8K – 933
2018
Q2 		$8K Buy
+22,574
New +$11.1K ﹤0.01% 760

Other funds holding PAVMZ

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
MRCM
M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return
LWAC
Laurel Wealth Advisors (California) Solana Beach, California $1.01B AUM 13.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hudson Bay Capital Management's PAVMZ Position: Q3 2018 in Review

Hudson Bay Capital Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q3 2018, closing a stake of 22,574 shares — an estimated $8K sold.

Hudson Bay Capital Management first reported a position in PAVMZ in Q2 2018 and held it in 1 quarter. The position peaked at $8K in Q2 2018. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q3 2018.

  • Hudson Bay Capital Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q3 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 22,574 PAVmed Inc. Series Z Warrant shares in Q3 2018, an estimated $8K.
  • Hudson Bay Capital Management first reported a position in PAVmed Inc. Series Z Warrant in Q2 2018 and held it in 1 quarter.
  • Hudson Bay Capital Management's PAVmed Inc. Series Z Warrant position peaked at $8K in Q2 2018.
  • 6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q3 2018.

Based on Hudson Bay Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.